Discontinued — last reported Q1 '24
MetLife Corporate and Other — Other revenues decreased by 3.9% to $98.00M in Q1 2024 compared to the prior quarter. Year-over-year, this metric declined by 3.0%, from $101.00M to $98.00M. Over 2 years (FY 2021 to FY 2023), Corporate and Other — Other revenues shows relatively stable performance with a -1.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests higher non-core business activity or one-time gains, while a decrease may indicate reduced ancillary service income or lower miscellaneous business activity.
This metric represents the aggregate revenue streams within the corporate segment that are not classified as core insura...
Peers often report this under 'Other Revenue' or 'Miscellaneous Income' within their corporate or non-operating segments.
met_segment_corporate_and_other_other_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $109.00M | $108.00M | $117.00M | $101.00M | $98.00M | $96.00M | $101.00M | $101.00M | $106.00M | $103.00M | $102.00M | $98.00M |
| QoQ Change | — | -0.9% | +8.3% | -13.7% | -3.0% | -2.0% | +5.2% | +0.0% | +5.0% | -2.8% | -1.0% | -3.9% |
| YoY Change | — | — | — | — | -10.1% | -11.1% | -13.7% | +0.0% | +8.2% | +7.3% | +1.0% | -3.0% |